Transfer of shares to CEO
Transfer of shares to CEO
Medistim ASA has transferred 12,000 shares to Medistim CEO Kari E. Krogstad, at
the last traded share price in 2022, of 233.00 NOK per share. This is in
accordance with her compensation agreement with the company, as described in the
Company's Annual Report. After the transfer, Kari E. Krogstad holds a total of
75,802 shares in the company and Medistim ASA holds 75,033 own shares.